Verge HealthTech Fund

Verge HealthTech Fund, established in 2018 and based in Singapore, is a venture capital firm focused on early-stage investments in global healthcare technology companies. It targets innovative solutions that address disease prevention, management, and health system efficiency, with a particular relevance to emerging Asian markets. The firm seeks and supports visionary founders creating transformative healthtech companies, aiming to foster their growth and scale, regardless of their origin, from Dhaka's streets to Oxford's labs.

Joseph Mocanu

Founder, Managing Partner

Scarlett Chen

Managing Partner

21 past transactions

CareLoop Health

Seed Round in 2025
CareLoop Health, originating from the University of Manchester, offers a digital platform that supports patients with mental health issues. It enables healthcare professionals to remotely monitor and track patient symptoms, while providing patients with personalized resources to manage their conditions. The platform uses predictive analytics to anticipate future mental health problems, helping to prevent escalation or relapse, and ultimately aims to reduce crises in mental health.

Prosoma

Seed Round in 2025
Prosoma is a digital therapeutics company focused on improving healthcare for oncology patients through innovative technology. It develops a clinically validated self-care mobile application designed to address the behavioral and mental health needs of cancer patients, ultimately enhancing their quality of life and treatment outcomes. Combining expertise in medicine, engineering, and psychology, Prosoma leverages advancements in artificial intelligence and mobile technology to deliver tailored solutions for individual patient conditions. By providing comprehensive support, the company aims to facilitate the healing process, reduce stress levels, and help patients establish healthy habits during their recovery. Additionally, Prosoma's platform offers valuable data for healthcare providers and pharmaceutical companies, contributing to cost savings for healthcare systems while increasing treatment efficacy.

HELLO INSIDE

Seed Round in 2024
HELLO INSIDE is a scientific self-care company focused on empowering individuals to engage in data-driven conversations about their health. The company offers a health monitoring application that integrates with a medical-grade continuous glucose monitoring device, enabling real-time measurement of blood sugar levels. This technology syncs with a mobile application, providing users with insights into their glucose levels, trends, and patterns. By offering personalized coaching and educational content, HELLO INSIDE helps users make informed decisions to enhance their metabolic health, optimize fitness, and promote longevity. The company's mission is to foster a new self-care movement that is truly personalized, rooted in science, and dedicated to creating a healthier future for individuals and communities.

BrainCapture

Venture Round in 2024
Operator of a medical technology company intended to offer affordable EEG (electroencephalogram) scans and interpretations for epilepsy patients. The company provides an affordable, Bluetooth-enabled electrode cap to access and interpret medical information from the brain which is uploaded to the cloud, and offers remote diagnosis by neurologists, enabling patients in low- and middle-income countries to get diagnosed and treated for epilepsy.

RetiSpec

Series A in 2024
RetiSpec is a company focused on advancing early detection of Alzheimer’s Disease through its innovative non-invasive eye scanning technology. By employing AI-driven retinal imaging, RetiSpec's solution enables healthcare providers to identify neurodegenerative disease markers during a simple eye exam. This approach facilitates early diagnosis, allowing clinicians to intervene with emerging therapeutics before symptoms arise, thereby potentially impacting the progression of the disease. RetiSpec aims to make early detection accessible and affordable, contributing significantly to the management of Alzheimer's Disease.

Pathway Medical

Seed Round in 2023
Pathway is a health technology company focused on enhancing access to essential medical information for clinicians and patients during the care journey. The company develops a point-of-care reference tool that provides rapid access to evidence-based clinical guidelines. By organizing and condensing medical literature, Pathway aims to make critical information more accessible and easier to understand for healthcare professionals. This approach enables clinicians to work more efficiently, ultimately improving patient outcomes. Leveraging artificial intelligence and big data, Pathway creates a medical knowledge graph and software solutions that integrate evidence-based medicine into clinical practice.

DoctorKoi

Seed Round in 2022
DoctorKoi is a healthcare technology company based in Dhaka, Bangladesh, focused on digitizing the country's health sector. It operates an online platform that connects patients with doctors, allowing users to search for medical practitioners by location and specialty, and facilitating appointment bookings. The company's primary offering includes Digital RX, a prescription writing program that enables doctors to generate prescriptions quickly and efficiently. Additionally, DoctorKoi provides online consultation services with specialized doctors, enhancing doctor-patient communication and improving access to medical care in Bangladesh. Through these services, DoctorKoi aims to streamline the healthcare process and implement technological solutions across the healthcare ecosystem.

Shen.AI

Seed Round in 2022
Shen.AI is clinically proven software technology for accurate measurement of Blood Pressure, Heart Rate, Breathing Rate and other vital-signs through 60s face-scan only with a smartphone or computer. It is encapsulated into SDK easily deployable in mobile apps and web on all platforms and browsers.

VitruvianMD

Seed Round in 2021
VitruvianMD is a MedTech company specializing in the development of advanced diagnostic assistance software tools tailored for medical laboratories, with a strong emphasis on fertility diagnostics. By integrating biomedical engineering and cutting-edge artificial intelligence, VitruvianMD provides high-accuracy diagnostic solutions that are both affordable and accessible, particularly in emerging markets. The company has created a cloud-based tool that optimizes the selection of high-quality sperm for assisted reproduction, enhancing the accuracy and efficiency of medical diagnostics. This innovative approach enables healthcare providers and laboratories to reduce costs and improve service delivery through faster turnaround times, ultimately benefiting patients and their healthcare experiences.

Highfield Diagnostics

Venture Round in 2021
Highfield Diagnostics is a technology spinout from the University of Southampton’s Optoelectronics Research Centre, led by Professor Rob Eason and Dr. Collin Sones. The company specializes in the development of lateral flow devices that leverage advanced laser technology to produce a patterned paper substrate. This innovation enables the creation of rapid, portable tests capable of diagnosing multiple medical conditions simultaneously. By utilizing a unique laser-based platform, Highfield Diagnostics enhances traditional lateral flow manufacturing processes, providing efficient and accessible point-of-care testing services for clients in the healthcare sector.

Saludtools

Pre Seed Round in 2021
Saludtools is an innovative healthcare technology company focused on enhancing the patient care experience through its AI-powered platform. The company aims to streamline the medical record-keeping process, allowing healthcare providers to focus more on patient interaction rather than administrative tasks. Its digital platform facilitates virtual consultations via mobile applications, enabling medical personnel to conduct video calls, upload clinical laboratory results, schedule appointments, and transfer medical records electronically. By improving access to medical services and fostering better communication between patients and doctors, Saludtools seeks to transform the healthcare sector while ensuring that productivity and empathy coexist in the patient care experience.

Shen.AI

Pre Seed Round in 2020
Shen.AI is clinically proven software technology for accurate measurement of Blood Pressure, Heart Rate, Breathing Rate and other vital-signs through 60s face-scan only with a smartphone or computer. It is encapsulated into SDK easily deployable in mobile apps and web on all platforms and browsers.

iWEECARE

Seed Round in 2020
iWEECARE, founded in Taipei, Taiwan in 2014, specializes in the development of innovative temperature monitoring solutions for infants. The company has created the Temp Pal®, a smart wearable thermometer patch designed to continuously measure and analyze a baby's body temperature. By collaborating with electronics manufacturers and utilizing advanced technology, iWEECARE aims to provide a user-friendly product that enhances the experience of temperature monitoring for parents and caregivers. The Temp Pal® not only offers real-time data but also generates alerts, ensuring that caretakers can easily monitor their child's health with greater convenience and reliability. Driven by a team of parents and expecting couples, iWEECARE is committed to addressing the challenges associated with monitoring infant temperatures, ultimately easing the worries of caregivers.

Mobio Interactive

Seed Round in 2020
Mobio Interactive Inc. is a Toronto-based company that specializes in developing digital tools aimed at enhancing mental health and well-being for both consumers and clinical populations. Founded in 2014, Mobio has created a range of applications, including Am Mindfulness, Wildflowers Mindfulness, and Actify Mindfulness, which offer medical-grade mindfulness training. These applications utilize an AI-powered digital theragnostic platform that provides clinically validated psychotherapy programs tailored to individual users. They measure the efficacy of mindfulness practices through advanced techniques, including computer vision to assess heart rate, heart rate variability, breathing rate, and blood oxygen levels, without the need for wearable devices. This innovative approach enables users to remotely access personalized mental health support while facilitating the objective quantification of their stress and mood levels over time. Additionally, Mobio has expanded its operations to include offices in Zurich, Switzerland, and Shanghai, China, reflecting its commitment to addressing the growing global demand for effective mental healthcare solutions.

Healthy Networks

Funding Round in 2020
Healthy Networks, based in Minsk, Belarus, specializes in the development of innovative medical technology, focusing on respiratory health. Its flagship product, LungPass, is a smart stethoscope designed to analyze lung sounds and symptoms, enabling it to accurately distinguish between serious and mild respiratory conditions. The device is user-friendly, precise, and affordable, positioning it as an essential tool for individuals seeking to manage their respiratory health and for healthcare providers aiming to enhance their service coverage.

AKUOS

Seed Round in 2020
AKUOS is a developer and retailer focused on creating innovative hearing aid devices aimed at restoring and preserving listening abilities. The company designs stylish, functional products that incorporate advanced engineering and artificial intelligence to enhance everyday life for individuals with hearing loss. By eliminating the stigma associated with medical conditions, AKUOS offers a digital conductive hearing aid that is both affordable and discreet, presented in the form of stylish eyeglasses. The devices not only address hearing disabilities but also expand users' capabilities, allowing them to live more fulfilling lives through human-centric design and technology.

Kipuwex

Seed Round in 2020
Kipuwex is a developer of a lightweight medical device that facilitates remote monitoring of patients' physiological parameters. This innovative IoT device enables healthcare professionals to continuously measure multiple clinically relevant vitals from patients, providing reliable data for disease management and assessment of well-being. The device can be monitored remotely through a mobile application, allowing healthcare providers to access critical health information anytime and anywhere. By converting physiological measurements into actionable insights, Kipuwex enhances the efficiency of diagnosing patients who are unable to visit healthcare facilities, thereby improving the overall quality of care.

Vigor

Convertible Note in 2019
Vigor helps reduce costs by making pulmonary rehabilitation and respiratory care accessible in every patient’s home through a unique combination of technology and experienced clinical care team.

reach52

Seed Round in 2019
reach52 is a Singapore-based social enterprise focused on improving healthcare access for rural communities through an offline-first mobile application. The company collaborates with partners in the pharmaceutical, medtech, consumer health, and insurance sectors to provide essential services such as screening, disease awareness, and affordable health products in underserved areas. By working with local implementation partners, reach52 not only expands its user base but also trains community members to manage health services and maintain the marketplace, creating livelihood opportunities in the process. The enterprise leverages data collected by local agents to drive awareness and engagement, optimizing healthcare programs through insights gained from on-the-ground experiences. Committed to connecting 250 million people globally to healthcare by 2030, reach52 aligns its mission with the United Nations Sustainable Development Goals related to health, gender equality, and economic growth.

iWEECARE

Seed Round in 2019
iWEECARE, founded in Taipei, Taiwan in 2014, specializes in the development of innovative temperature monitoring solutions for infants. The company has created the Temp Pal®, a smart wearable thermometer patch designed to continuously measure and analyze a baby's body temperature. By collaborating with electronics manufacturers and utilizing advanced technology, iWEECARE aims to provide a user-friendly product that enhances the experience of temperature monitoring for parents and caregivers. The Temp Pal® not only offers real-time data but also generates alerts, ensuring that caretakers can easily monitor their child's health with greater convenience and reliability. Driven by a team of parents and expecting couples, iWEECARE is committed to addressing the challenges associated with monitoring infant temperatures, ultimately easing the worries of caregivers.

Healthy Networks

Seed Round in 2018
Healthy Networks, based in Minsk, Belarus, specializes in the development of innovative medical technology, focusing on respiratory health. Its flagship product, LungPass, is a smart stethoscope designed to analyze lung sounds and symptoms, enabling it to accurately distinguish between serious and mild respiratory conditions. The device is user-friendly, precise, and affordable, positioning it as an essential tool for individuals seeking to manage their respiratory health and for healthcare providers aiming to enhance their service coverage.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.